Genomics, Populations, and Society

Section I Scientific aspects
1. From the double helix to personal genomes
2. Genetic and genomic technologies-an introduction
3. Computational genomics and bioinformatics
4. Bio-banks- organisation and the role 'Biopreservation & Biobanking

Section II Healthcare applications
5. The genomic and precision medicine in clinical practice- Current perspectives and future directions
6. Genomic Healthcare & Genomic health screening
7. Genomics and Digital health
8. Genetics, genomics and drug prescribing
9. Genomics and Infectious diseases: Lessons learnt from Covid-19 pandemic

Section III Socio-Cultural Aspects
10. Rethinking individual and community engagement with genomics in a digital world
11. Consanguinity in the Genomic Era - requirement of focused counseling
12. Aging genomics and society

Section IV Ethical Aspects
13. The environment population health ethics, & genomics
14. The expanding scope of gen-ethics: Harmonization of genetic and environmental concerns
15. Biobanks providing a trusted research environment for health data to advance collaborative research and digital transformation of health systems
16. Beyond the central dogma: ecogenomics and the implication for bioethics.

Section V Global health genomics
17. Global Globin Network (GGN)
18. Genome databases- challenges and expectations
19. Commercialization of genetic samples and information
20. The governance of international genomics' collaborations: Opportunities and challenges

Este título pertence ao(s) assunto(s) indicados(s). Para ver outros títulos clique no assunto desejado.

• Terapia genética
• Rastreio médico
• DNA e Genoma

"Race?; Age; Aging; Attitudes; Benefit-sharing; Biobank; Biobank locators; Biobanking; Biobanks; Bioethics; Chromosomal microarrays; Clinical genomics; Clinical practice; Clopidogrel; Commercialization; Community and individuality; Complex genetics; Consanguinity; Consent; COVID-19; Culture; Cyber security; Data infrastructure literacy; Data privacy and data accessibility; Deoxyribose nucleic acid; Digital applications; Digital health; Digital health regulations; Digital tools; Direct-to-consumer (DTC) genomics; Discrimination; Diversity; DNA; Double helix; Drug response; Ecological systems; Engagement; Enhancement; Environment; Environmental determinants of health; Environmental ethics; Environmentalism; Epigenetics; Ethical; Ethical, legal and social Issues (ELSI); Ethics; Expectations; Exploitation; Fair benefit sharing; Future medicine; Gene editing; Gene variant; Genetic testing; Genetics; Genome; Genome database; Genome sequencing; Genomic healthcare; Genomic medicine; Genomic resources; Genomics; Genomics research; Global Globin Network; Global health; Global Variome; Health data; Hemoglobinopathies; Human genome; Human genome project; Human genomics; Human rights; Human Variome Project; Inequity; Infertility; Justice; Law; Legal; Low-middle-income countries; Microbiome; Molecular biology; NGS; Offsprings; One Health; Participation and engagement; Pathogens; Personal genomics; Personalized healthcare; Personalized medicine; Pharmacogenomics; Pneumonia; Policies; Policy; PPP; Precision medicine; Preventive genomics; Proteomics; Public health; Rare Mendelian disease diagnostics; Right not to know; Screening; Sequencing; Sickle cell disease; Social issues; Socioeconomic gains; Sources of biospecimens; Stakeholders; Stigma; Thalassemia; Thought-experiments; Translation; Trusted research environment (TRE); Vaccine; Values; Variant prioritization software; Whole exome sequencing; Whole genome sequencing